GR79055B - - Google Patents

Info

Publication number
GR79055B
GR79055B GR72452A GR830172452A GR79055B GR 79055 B GR79055 B GR 79055B GR 72452 A GR72452 A GR 72452A GR 830172452 A GR830172452 A GR 830172452A GR 79055 B GR79055 B GR 79055B
Authority
GR
Greece
Application number
GR72452A
Other languages
Greek (el)
Inventor
Gaetano Battelli
Diego Oldani
Alessandro Rigamonti
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of GR79055B publication Critical patent/GR79055B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR72452A 1982-09-23 1983-09-15 GR79055B (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Publications (1)

Publication Number Publication Date
GR79055B true GR79055B (enEXAMPLES) 1984-10-02

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72452A GR79055B (enEXAMPLES) 1982-09-23 1983-09-15

Country Status (20)

Country Link
US (1) US4670262A (enEXAMPLES)
JP (1) JPS5978117A (enEXAMPLES)
AT (1) AT382077B (enEXAMPLES)
AU (1) AU559499B2 (enEXAMPLES)
BE (1) BE897761A (enEXAMPLES)
CA (1) CA1211372A (enEXAMPLES)
CH (1) CH655852A5 (enEXAMPLES)
DE (1) DE3333024A1 (enEXAMPLES)
DK (1) DK157168C (enEXAMPLES)
FI (1) FI78236C (enEXAMPLES)
FR (1) FR2533439B1 (enEXAMPLES)
GB (1) GB2127291B (enEXAMPLES)
GR (1) GR79055B (enEXAMPLES)
IE (1) IE56173B1 (enEXAMPLES)
IL (1) IL69752A (enEXAMPLES)
IT (1) IT1153974B (enEXAMPLES)
NL (1) NL8303211A (enEXAMPLES)
SE (1) SE464061B (enEXAMPLES)
SU (1) SU1424722A3 (enEXAMPLES)
ZA (1) ZA836904B (enEXAMPLES)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DK500185A (da) * 1984-11-02 1986-05-03 Johnson Matthey Plc Oploeseliggjort platinforbindelse
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
JPH06192109A (ja) * 1992-09-04 1994-07-12 Fuji Kagaku Kogyo Kk 抗腫瘍効果増強剤
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
PT1229922E (pt) * 1999-11-15 2007-09-12 Pharma Mar Sa Tratamento de cancros com aplidina.
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
KR20030038812A (ko) * 2000-10-12 2003-05-16 파르마 마르, 에스.에이. 암 치료 방법
AU2002243646B2 (en) 2001-01-25 2006-06-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
JP4272991B2 (ja) * 2001-09-21 2009-06-03 大日本住友製薬株式会社 凍結乾燥製剤
US20050004012A1 (en) * 2001-10-19 2005-01-06 Ramon Mangues Use of aplidine for the treatment of pancreatic cancer
RU2335294C2 (ru) * 2003-03-12 2008-10-10 Дана-Фарбер Кэнсер Инститьют, Инк. Аплидин для лечения множественной миеломы
UA83022C2 (uk) * 2003-03-12 2008-06-10 Фарма Мар, С.А. Аплідин для комбінованої терапії лейкозу та лімфоми
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
AU2007220050B2 (en) * 2006-02-28 2013-08-29 Pharma Mar, S.A. Improved antitumoral treatments
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
RU2010140888A (ru) * 2008-03-07 2012-04-20 Фарма Мар, С.А. (Es) Улучшенные противораковые терапии
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
JP5670335B2 (ja) 2008-09-25 2015-02-18 セファロン、インク. ベンダムスチン液体製剤
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations

Also Published As

Publication number Publication date
SE8304920L (sv) 1984-03-24
FI78236C (fi) 1989-07-10
ZA836904B (en) 1984-10-31
SE8304920D0 (sv) 1983-09-13
CH655852A5 (de) 1986-05-30
AU1908983A (en) 1984-03-29
SE464061B (sv) 1991-03-04
IT1153974B (it) 1987-01-21
IL69752A (en) 1986-07-31
GB2127291A (en) 1984-04-11
CA1211372A (en) 1986-09-16
BE897761A (fr) 1984-01-02
AT382077B (de) 1987-01-12
DK424383A (da) 1984-03-24
IE832172L (en) 1984-03-23
DK157168C (da) 1990-04-09
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
GB2127291B (en) 1986-01-15
IL69752A0 (en) 1983-12-30
ATA326283A (de) 1986-06-15
JPS5978117A (ja) 1984-05-04
FR2533439A1 (fr) 1984-03-30
FR2533439B1 (fr) 1986-08-14
GB8324380D0 (en) 1983-10-12
FI833300A7 (fi) 1984-03-24
DK424383D0 (da) 1983-09-16
DE3333024A1 (de) 1984-03-29
DK157168B (da) 1989-11-20
NL8303211A (nl) 1984-04-16
IT8223396A0 (it) 1982-09-23
IE56173B1 (en) 1991-05-08
FI78236B (fi) 1989-03-31
AU559499B2 (en) 1987-03-12
FI833300A0 (fi) 1983-09-15

Similar Documents

Publication Publication Date Title
FR2521793B1 (enEXAMPLES)
CH655644B (enEXAMPLES)
CH646569GA3 (enEXAMPLES)
FR2519531B3 (enEXAMPLES)
FR2520389B1 (enEXAMPLES)
DE3348027A1 (enEXAMPLES)
DE3348116A1 (enEXAMPLES)
GR79055B (enEXAMPLES)
CH655653B (enEXAMPLES)
DE3348365A1 (enEXAMPLES)
CH655565B (enEXAMPLES)
CH671314GA3 (enEXAMPLES)
FR2520398B1 (enEXAMPLES)
FR2526539B1 (enEXAMPLES)
FR2525032B1 (enEXAMPLES)
FR2523178B1 (enEXAMPLES)
FR2519723B3 (enEXAMPLES)
FR2520417B1 (enEXAMPLES)
FR2519660B1 (enEXAMPLES)
FR2520895B1 (enEXAMPLES)
FR2520589B1 (enEXAMPLES)
FR2519543B1 (enEXAMPLES)
FR2520134B1 (enEXAMPLES)
CH655583B (enEXAMPLES)
CH656692B (enEXAMPLES)